Asthma Trial, Recruiting NCT06573450 Sponsor: Henan University of Traditional Chinese Medicine Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT06573450
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People diagnosed with allergic rhinitis (AR), bronchial asthma (BA), or combined allergic rhinitis and asthma syndrome (CARAS), based on standard Western medical diagnostic criteria
  • People whose condition also matches one of three specific Traditional Chinese Medicine patterns: lung qi deficiency, phlegm-heat congestion of the lung, or wind-heat offending the lung (confirm with trial site)
  • People aged between 18 and 80 years
  • People who have agreed to take part voluntarily and have signed a consent form
  • People who have not taken part in any other clinical study in the month before joining this trial

Who may not be able to join:

  • People who have vasomotor rhinitis, eosinophilic non-allergic rhinitis, or other non-allergic conditions that cause nasal congestion or a runny nose
  • People who are currently taking part in another drug trial
  • People who also have another serious ongoing illness affecting other parts of the body
  • Women who are pregnant or currently breastfeeding
  • People who have confusion, a disorder of consciousness, dementia, or any psychiatric condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13526621325

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Henan University of Traditional Chinese Medicine
Registry
ClinicalTrials.gov
Start date
1 April 2023
Est. completion
30 May 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Interleukin-2、4、5、13 (IL-2、4、5、13); Interferon-γ (IFN-γ); Tumor necrosis factor-β (TNF-β); Eosinophil cationic proteins (ECP); Immunoglobulin E (IgE)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov